Valuation: Shivalik Rasayan Limited

Market Cap 3.49B 36.53M 31.55M 29.64M 26.96M 50.69M 51.52M 347M 136M 1.75B 137M 134M 5.81B P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 4.26B 44.55M 38.48M 36.16M 32.89M 61.83M 62.85M 424M 166M 2.13B 167M 164M 7.09B EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
41.75%
Yield 2024
0.09%
Yield 2025 0.08%
08-14 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
25-08-12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-05-29 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
25-04-23 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day-4.99%
1 week-2.11%
Current month+2.49%
1 month+15.99%
3 months+0.58%
6 months-12.27%
Current year-28.86%
1 week 250
Extreme 250
269
1 month 215.05
Extreme 215.05
271.4
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
524
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 62.04
Extreme 62.04
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 2018-11-16
Director of Finance/CFO - 2001-10-31
Chief Tech/Sci/R&D Officer - 2024-01-10
Director TitleAgeSince
Chairman 62 2002-02-22
Director/Board Member 67 2003-07-17
Director/Board Member - 2018-11-12
Date Insider Type Main position Quantity % Market Cap.
7/1/24 Don 21,500 0.1382%
6/26/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
-4.99%-2.11%-50.17%-66.69% 43.89M
+1.17%-0.20%+6.86%+53.33% 51.16B
+0.11%-.--%-.--%-.--% 12.96B
+0.74%+0.34%+21.14%+171.04% 10.56B
+0.31%-4.02%+11.03%+67.48% 7.81B
+2.97%+4.52%-10.19%-10.05% 7.16B
-1.79%-4.97%-17.78%+71.75% 5.47B
-0.23%+0.94%+36.69%+47.70% 5.17B
+0.57%+0.12%-17.85%-2.89% 4.99B
-0.64%-9.52%-33.80%-35.11% 3.97B
Average -0.23%-0.58%-5.41%+29.66% 10.93B
Weighted average by Cap. +0.52%-0.31%+4.16%+50.07%

Financials

2024 2025
Net sales 2.72B 28.4M 24.53M 23.05M 20.96M 39.41M 40.06M 270M 106M 1.36B 107M 104M 4.52B 3.1B 32.37M 27.96M 26.27M 23.89M 44.92M 45.66M 308M 120M 1.55B 122M 119M 5.15B
Net income 127M 1.33M 1.15M 1.08M 982K 1.85M 1.88M 12.65M 4.95M 63.68M 4.99M 4.88M 212M 167M 1.75M 1.51M 1.42M 1.29M 2.42M 2.46M 16.6M 6.49M 83.61M 6.56M 6.41M 278M
Net Debt 482M 5.04M 4.36M 4.09M 3.72M 7M 7.11M 47.96M 18.75M 242M 18.94M 18.53M 803M 768M 8.03M 6.93M 6.51M 5.92M 11.14M 11.32M 76.34M 29.85M 384M 30.14M 29.48M 1.28B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
26-08-17 253.15 -4.99% 3,527
26-08-14 ₹266.45 +1.72% 2,439
26-08-13 ₹261.95 -2.51% 4,163
26-08-12 ₹268.70 +3.75% 2,898
26-08-11 ₹259.00 +0.15% 3,535
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock